Cardiac Effects of Muscarinic Receptor Antagonists Used for Voiding Dysfunction

British Journal of Clinical Pharmacology - United Kingdom
doi 10.1111/j.1365-2125.2010.03813.x
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Synthesis of New Cardioselective M2 Muscarinic Receptor Antagonists.

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
2000English

Should Hormone Replacement Therapy Be Used in Postmenopausal Women for Voiding Dysfunction?

Canadian Urological Association Journal
Urology
2013English

Functional and Direct Binding Studies Using Subtype Selective Muscarinic Receptor Antagonists

British Journal of Pharmacology
Pharmacology
1988English

Label-Free Kinetics: Exploiting Functional Hemi-Equilibrium to Derive Rate Constants for Muscarinic Receptor Antagonists

Molecular Pharmacology
Molecular MedicinePharmacology
2015English

Effects of YM905, a Novel Muscarinic M3-Receptor Antagonist, on Experimental Models of Bowel Dysfunction in Vivo

The Japanese Journal of Pharmacology
2001English

A Search for Selective Antagonists at M2 Muscarinic Receptors

British Journal of Pharmacology
Pharmacology
1985English

Novel Long-Acting Antagonists of Muscarinic Acetylcholine Receptors

British Journal of Pharmacology
Pharmacology
2018English

The Therapeutic Effects and Pathophysiology of Botulinum Toxin a on Voiding Dysfunction Due to Urethral Sphincter Dysfunction

Toxins
MutagenesisToxicologyHealth
2019English

Role of Purinergic Signaling in Voiding Dysfunction

Current Bladder Dysfunction Reports
BiochemistryMolecular Biology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy